Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.69
-$0.03-4.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.29M | 13.48M | 5.56M | 6.18M | 11.97M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 967.90K | 1.21M | 1.25M | 1.05M | 1.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.26M | 14.68M | 6.81M | 7.23M | 13.50M |
|
|
|||||
| Total Current Assets | 6.26M | 14.68M | 6.81M | 7.23M | 13.50M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 819.70K | 819.70K | 819.70K | 819.70K | -- |
| Total Assets | 7.08M | 15.50M | 7.63M | 8.05M | 13.50M |
|
|
|||||
| Total Accounts Payable | 4.72M | 6.28M | 8.78M | 4.69M | 5.72M |
| Total Accrued Expenses | 6.08M | 7.36M | 8.24M | 8.60M | 8.06M |
| Short-term Debt | 224.30K | 458.20K | 83.00K | 207.50K | 332.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 482.90K | 500.60K | 428.80K | 445.40K | 377.40K |
| Total Other Current Liabilities | 482.90K | 500.60K | 428.80K | 445.40K | 377.40K |
| Total Current Liabilities | 11.51M | 14.60M | 17.53M | 13.94M | 14.49M |
|
|
|||||
| Total Current Liabilities | 11.51M | 14.60M | 17.53M | 13.94M | 14.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 224.30K | 458.20K | 83.00K | 207.50K | 332.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.80K | 89.00K | 77.90K | 150.20K | 350.50K |
| Total Liabilities | 11.54M | 14.69M | 17.61M | 14.09M | 14.84M |
|
|
|||||
| Common Stock & APIC | 166.25M | 165.09M | 148.03M | 143.61M | 140.44M |
| Retained Earnings | -170.71M | -164.27M | -158.01M | -149.65M | -141.79M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.46M | 812.60K | -9.98M | -6.04M | -1.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.46M | 812.60K | -9.98M | -6.04M | -1.35M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.46M | 812.60K | -9.98M | -6.04M | -1.35M |
|
|
|||||